Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in aicardi-goutières syndrome

Alberto Izzotti, Mariagrazia Longobardi, Cristina Cartiglia, Francesco Anzuini, Patrizio Arrigo, Elisa Fazzi, Simona Orcesi, Roberta La Piana, Alessandra Pulliero

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aicardi-Goutières syndrome is a rare encephalopathy of mutational origin characterized by increased levels of interferon alpha in cerebrospinal fluid. The aim of this study was to explore the influence of different Aicardi-Goutières syndrome genotypes on the clinical course of patients, seeking to identify specific gene expression profiles able to explain Aicardi-Goutières syndrome phenotype differences. We detected the occurrence of Aicardi-Goutières syndrome mutations in 21 patients and compared microarray gene-expression data of cerebrospinal fluid lymphocytes with clinical variables. The levels of interferon alpha in cerebrospinal fluid were high in all patients; we found differences in the expression of genes encoding for Toll-like receptor, endogenous RNases, T lymphocyte activation, angiogenesis inhibition, and peripheral interferon alpha production. These results indicate that further to interferon alpha production in the central nervous system, a variety of other pathogenic mechanisms is activated in Aicardi-Goutières syndrome to various degrees in different patients, thus explaining the interindividual difference in Aicardi-Goutières syndrome course.

Original languageEnglish
Pages (from-to)51-60
Number of pages10
JournalJournal of Child Neurology
Volume27
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Aicardi Syndrome
Ribonucleases
Interferon-alpha
Mutation
Genes
Cerebrospinal Fluid
Gene Expression
Toll-Like Receptors
Brain Diseases
Lymphocyte Activation
Transcriptome
three prime repair exonuclease 1
Central Nervous System
Genotype
Lymphocytes
T-Lymphocytes
Phenotype

Keywords

  • Aicardi-Goutières syndrome mutations
  • Brain damage
  • Interferon alpha

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in aicardi-goutières syndrome. / Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina; Anzuini, Francesco; Arrigo, Patrizio; Fazzi, Elisa; Orcesi, Simona; Piana, Roberta La; Pulliero, Alessandra.

In: Journal of Child Neurology, Vol. 27, No. 1, 01.2012, p. 51-60.

Research output: Contribution to journalArticle

Izzotti, Alberto ; Longobardi, Mariagrazia ; Cartiglia, Cristina ; Anzuini, Francesco ; Arrigo, Patrizio ; Fazzi, Elisa ; Orcesi, Simona ; Piana, Roberta La ; Pulliero, Alessandra. / Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in aicardi-goutières syndrome. In: Journal of Child Neurology. 2012 ; Vol. 27, No. 1. pp. 51-60.
@article{ba80fd12494a4301b065db3b576f6214,
title = "Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in aicardi-gouti{\`e}res syndrome",
abstract = "Aicardi-Gouti{\`e}res syndrome is a rare encephalopathy of mutational origin characterized by increased levels of interferon alpha in cerebrospinal fluid. The aim of this study was to explore the influence of different Aicardi-Gouti{\`e}res syndrome genotypes on the clinical course of patients, seeking to identify specific gene expression profiles able to explain Aicardi-Gouti{\`e}res syndrome phenotype differences. We detected the occurrence of Aicardi-Gouti{\`e}res syndrome mutations in 21 patients and compared microarray gene-expression data of cerebrospinal fluid lymphocytes with clinical variables. The levels of interferon alpha in cerebrospinal fluid were high in all patients; we found differences in the expression of genes encoding for Toll-like receptor, endogenous RNases, T lymphocyte activation, angiogenesis inhibition, and peripheral interferon alpha production. These results indicate that further to interferon alpha production in the central nervous system, a variety of other pathogenic mechanisms is activated in Aicardi-Gouti{\`e}res syndrome to various degrees in different patients, thus explaining the interindividual difference in Aicardi-Gouti{\`e}res syndrome course.",
keywords = "Aicardi-Gouti{\`e}res syndrome mutations, Brain damage, Interferon alpha",
author = "Alberto Izzotti and Mariagrazia Longobardi and Cristina Cartiglia and Francesco Anzuini and Patrizio Arrigo and Elisa Fazzi and Simona Orcesi and Piana, {Roberta La} and Alessandra Pulliero",
year = "2012",
month = "1",
doi = "10.1177/0883073811413582",
language = "English",
volume = "27",
pages = "51--60",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in aicardi-goutières syndrome

AU - Izzotti, Alberto

AU - Longobardi, Mariagrazia

AU - Cartiglia, Cristina

AU - Anzuini, Francesco

AU - Arrigo, Patrizio

AU - Fazzi, Elisa

AU - Orcesi, Simona

AU - Piana, Roberta La

AU - Pulliero, Alessandra

PY - 2012/1

Y1 - 2012/1

N2 - Aicardi-Goutières syndrome is a rare encephalopathy of mutational origin characterized by increased levels of interferon alpha in cerebrospinal fluid. The aim of this study was to explore the influence of different Aicardi-Goutières syndrome genotypes on the clinical course of patients, seeking to identify specific gene expression profiles able to explain Aicardi-Goutières syndrome phenotype differences. We detected the occurrence of Aicardi-Goutières syndrome mutations in 21 patients and compared microarray gene-expression data of cerebrospinal fluid lymphocytes with clinical variables. The levels of interferon alpha in cerebrospinal fluid were high in all patients; we found differences in the expression of genes encoding for Toll-like receptor, endogenous RNases, T lymphocyte activation, angiogenesis inhibition, and peripheral interferon alpha production. These results indicate that further to interferon alpha production in the central nervous system, a variety of other pathogenic mechanisms is activated in Aicardi-Goutières syndrome to various degrees in different patients, thus explaining the interindividual difference in Aicardi-Goutières syndrome course.

AB - Aicardi-Goutières syndrome is a rare encephalopathy of mutational origin characterized by increased levels of interferon alpha in cerebrospinal fluid. The aim of this study was to explore the influence of different Aicardi-Goutières syndrome genotypes on the clinical course of patients, seeking to identify specific gene expression profiles able to explain Aicardi-Goutières syndrome phenotype differences. We detected the occurrence of Aicardi-Goutières syndrome mutations in 21 patients and compared microarray gene-expression data of cerebrospinal fluid lymphocytes with clinical variables. The levels of interferon alpha in cerebrospinal fluid were high in all patients; we found differences in the expression of genes encoding for Toll-like receptor, endogenous RNases, T lymphocyte activation, angiogenesis inhibition, and peripheral interferon alpha production. These results indicate that further to interferon alpha production in the central nervous system, a variety of other pathogenic mechanisms is activated in Aicardi-Goutières syndrome to various degrees in different patients, thus explaining the interindividual difference in Aicardi-Goutières syndrome course.

KW - Aicardi-Goutières syndrome mutations

KW - Brain damage

KW - Interferon alpha

UR - http://www.scopus.com/inward/record.url?scp=84856893266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856893266&partnerID=8YFLogxK

U2 - 10.1177/0883073811413582

DO - 10.1177/0883073811413582

M3 - Article

C2 - 21862834

AN - SCOPUS:84856893266

VL - 27

SP - 51

EP - 60

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 1

ER -